TY - JOUR
T1 - Long-Term Durability of Transcatheter Aortic Valves in Patients With Bicuspid Aortic Stenosis
AU - Jia, Yuheng
AU - Maznyczka, Annette
AU - Boiago, Mauro
AU - Khokhar, Arif
AU - Tomii, Daijiro
AU - Neylon, Antoinette
AU - Danthine, Pauline
AU - Levesque, Thomas
AU - Bamford, Paul
AU - Toggweiler, Stefan
AU - Moccetti, Federico
AU - Piuhola, Jarkko
AU - Adamo, Marianna
AU - Massussi, Mauro
AU - Ielasi, Alfonso
AU - Montorfano, Matteo
AU - Costa, Giulia
AU - Swaans, Martin
AU - Overduin, Daniël C.
AU - Servoz, Clément
AU - Gandolfo, Caterina
AU - Guðmundsdóttir, Ingibjörg Jóna
AU - Salizzoni, Stefano
AU - Wykrzykowska, Joanna J.
AU - van Bergeijk, Kees H.
AU - Buono, Andrea
AU - Hartikainen, Tau
AU - Noble, Stephane
AU - Mylotte, Darren
AU - Brecker, Stephen
AU - Thabit, Ahmed
AU - Mangieri, Antonio
AU - Agostoni, Pierfrancesco
AU - Bunc, Matjaž
AU - Vanhaverbeke, Maarten
AU - Bosmans, Johan
AU - Eltchaninoff, Hélène
AU - Latib, Azeem
AU - Blackman, Daniel
AU - Van Mieghem, Nicolas M.
AU - Feng, Yuan
AU - Kim, Won Keun
AU - Pilgrim, Thomas
AU - Prendergast, Bernard
AU - Tchétché, Didier
AU - Chen, Mao
AU - De Backer, Ole
N1 - Publisher Copyright:
© 2025 The Author(s). Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC.
PY - 2025/9/1
Y1 - 2025/9/1
N2 - Background: Data concerning the long-term durability of transcatheter aortic valves (TAVs) in patients with bicuspid aortic stenosis (AS) are lacking. Aims: The study aims to report data on long-term valve durability following transcatheter aortic valve replacement (TAVR) in bicuspid AS. Methods: This multicentre registry included patients who underwent TAVR for bicuspid AS with at least 2-year echocardiographic follow-up. The incidence of structural valve deterioration (SVD), bioprosthetic valve dysfunction (BVD), and bioprosthetic valve failure (BVF) was determined according to Valve Academic Research Consortium (VARC)-3 criteria. Results: Among 894 patients (mean age: 75.6 years; 39% female), the median echocardiographic follow-up was 48.7 months with a 5-year cumulative incidence of moderate-to-severe SVD, severe SVD, severe BVD, and BVF of 8.1%, 3.2%, 11.4%, and 6.1%, respectively. Younger age (≤ 75 years) was associated with a higher likelihood of reintervention (HR 2.40, log-rank p = 0.04). TAV downsizing was associated with higher rates of moderate-to-severe SVD (HR 3.05, log-rank p < 0.001), severe BVD (HR 2.07, log-rank p = 0.003), and BVF (HR 3.25, log-rank p = 0.002). In the sub-group with small annuli (area ≤ 430 mm2), implantation of balloon-expandable TAVs was associated with a higher rate of BVD in comparison with self-expanding TAVs (HR: 3.27, log-rank p = 0.008). Conclusions: TAVs demonstrated favorable 5-year durability in patients with bicuspid AS, although younger patients were more likely to require valve reintervention. Nominal TAV sizing was associated with better durability outcomes as compared to TAV downsizing. Self-expanding valves were associated with superior hemodynamics in patients with small annuli.
AB - Background: Data concerning the long-term durability of transcatheter aortic valves (TAVs) in patients with bicuspid aortic stenosis (AS) are lacking. Aims: The study aims to report data on long-term valve durability following transcatheter aortic valve replacement (TAVR) in bicuspid AS. Methods: This multicentre registry included patients who underwent TAVR for bicuspid AS with at least 2-year echocardiographic follow-up. The incidence of structural valve deterioration (SVD), bioprosthetic valve dysfunction (BVD), and bioprosthetic valve failure (BVF) was determined according to Valve Academic Research Consortium (VARC)-3 criteria. Results: Among 894 patients (mean age: 75.6 years; 39% female), the median echocardiographic follow-up was 48.7 months with a 5-year cumulative incidence of moderate-to-severe SVD, severe SVD, severe BVD, and BVF of 8.1%, 3.2%, 11.4%, and 6.1%, respectively. Younger age (≤ 75 years) was associated with a higher likelihood of reintervention (HR 2.40, log-rank p = 0.04). TAV downsizing was associated with higher rates of moderate-to-severe SVD (HR 3.05, log-rank p < 0.001), severe BVD (HR 2.07, log-rank p = 0.003), and BVF (HR 3.25, log-rank p = 0.002). In the sub-group with small annuli (area ≤ 430 mm2), implantation of balloon-expandable TAVs was associated with a higher rate of BVD in comparison with self-expanding TAVs (HR: 3.27, log-rank p = 0.008). Conclusions: TAVs demonstrated favorable 5-year durability in patients with bicuspid AS, although younger patients were more likely to require valve reintervention. Nominal TAV sizing was associated with better durability outcomes as compared to TAV downsizing. Self-expanding valves were associated with superior hemodynamics in patients with small annuli.
UR - https://www.scopus.com/pages/publications/105009867842
U2 - 10.1002/ccd.31742
DO - 10.1002/ccd.31742
M3 - Article
C2 - 40611498
AN - SCOPUS:105009867842
SN - 1522-1946
VL - 106
SP - 1746
EP - 1757
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
IS - 3
ER -